Variant lineages of human papillomavirus type 18 in Northeast China populations characterized by sequence analysis of e6, E7, and L1 regions

International Journal of Gynecological Cancer

Volumn 22, Issue 6, 2012, Pages 930-936

  Sun, Zhengrong ^a   Liu, Jianhua ^a   Wang, Guili ^a   Zhou, Weiqiang ^a   Liu, Chao ^a   Ruan, Qiang ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

E6 E7 L1 genes; Genetic diversity; HPV 18

Indexed keywords

CAPSID PROTEIN L1; PROTEIN E6; PROTEIN E7; VIRUS DNA;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; ASIAN AMERICAN; CARBOXY TERMINAL SEQUENCE; CHINA; DNA SEQUENCE; EUROPEAN AMERICAN; FEMALE; GENETIC VARIABILITY; GENOTYPE; HISTOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; SEQUENCE ANALYSIS; UTERINE CERVIX CANCER; VIRUS MUTATION; VIRUS STRAIN;

ADOLESCENT; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CAPSID PROTEINS; CHINA; DNA-BINDING PROTEINS; FEMALE; GENETIC VARIATION; HUMAN PAPILLOMAVIRUS 18; HUMANS; MIDDLE AGED; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; SEQUENCE ANALYSIS, DNA; YOUNG ADULT;

EID: 84863620324     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e318253a994     Document Type: Article

References (28)

1. Cogliano V, Baan R, Straif K, et al. Carcinogenicity of human papillomaviruses. Lancet Oncol. 2005;6:204.
2. Rodriguez AC, Schiffman M, Herrero R, et al. Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections. J Natl Cancer Inst. 2008;100:513-517.
3. Castle PE, Rodriguez AC, Burk RD, et al. Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study. BMJ. 2009;339:b2569.
4. Jit M, Gay N, Soldan K, et al. Estimating progression rates for human papillomavirus infection from epidemiological data. Med Decis Making. 2010;30:84-98.
5. Smith JS, Lindsay L, Hoots B, et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer. 2007;121:621-632.
6. Khan MJ, Castle PE, Lorincz AT, et al. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst. 2005;97:1072-1079.
7. Burk RD, Terai M, Gravitt PE, et al. Distribution of human papillomavirus types 16 and 18 variants in squamous cell carcinomas and adenocarcinomas of the cervix. Cancer Res. 2003;63:7215-7220.
8. Cruz MR, Cerqueira DM, Cruz WB, et al. Prevalence of human papillomavirus type 16 variants in the Federal District, Central Brazil. Mem Inst Oswaldo Cruz. 2004;99:281-282.
9. Alencar TR, Cerqueira DM, da Cruz MR, et al. New HPV-16 European and non-European variants in Central Brazil. Virus Genes. 2007;35:1-4.
10. Ong CK, Chan SY, Campo MS, et al. Evolution of human papillomavirus type 18: an ancient phylogenetic root in Africa and intratype diversity reflect coevolution with human ethnic groups. J Virol. 1993;67:6424-6431.
11. Sichero L, Ferreira S, Trottier H, et al. High grade cervical lesions are caused preferentially by non-European variants of HPVs 16 and 18. Int J Cancer. 2007;120:1763-1768.
12. Xi LF, Koutsky LA, Hildesheim A, et al. Risk for high-grade cervical intraepithelial neoplasia associated with variants of human papillomavirus types 16 and 18. Cancer Epidemiol Biomarkers Prev. 2007;16:4-10.
13. Liu X, Zhang S, Ruan Q, et al. Prevalence and type distribution of human papillomavirus in women with cervical lesions in Liaoning Province, China. Int J Gynecol Cancer. 2010;20:147-153.
14. Schlecht NF, Burk RD, Palefsky JM, et al. Variants of human papillomaviruses 16 and 18 and their natural history in human immunodeficiency virus-positive women. J Gen Virol. 2005;86:2709-2720.
15. Stewart A, Eriksson A, Manos M, et al. Intratype variation in 12 human papillomavirus types: a worldwide perspective. J Virol. 1996;70:3127-3136.
16. Hildesheim A, Schiffman M, Bromley C, et al. Human papillomavirus type 16 variants and risk of cervical cancer. J Natl Cancer Inst. 2001;93:315-318.
17. Pista A, Oliveira A, Barateiro A, et al. Molecular variants of human papillomavirus type 16 and 18 and risk for cervical neoplasia in Portugal. J Med Virol. 2007; 79:1889-1897.
18. Li N, Franceschi S, Howell-Jones R, et al. Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication. Int J Cancer. 2011;128:927-935.
19. Yamada T, Wheeler C, Halpern A, et al. Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments. J Virol. 1995;69:7743-7753.
20. Bernard HU. The clinical importance of the nomenclature, evolution and taxonomy of human papillomaviruses. J Clin Virol. 2005;32:S1YS6.
21. De Boer MA, Peters LA, Aziz MF, et al. Human papillomavirus type 18 variants: histopathology and E6/E7 polymorphisms in three countries. Int J Cancer. 2005;114:422-425.
22. De la Cruz-Hernández E, García-Carrancá A, Mohar-Betancourt A, et al. Differential splicing of E6 within human papillomavirus type 18 variants and functional consequences. J Gen Virol. 2005;86: 2459-2468.
23. Villa LL, Sichero L, Rahal P. Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. J Gen Virol. 2000;81:2959-2968.
24. Rose BR, Thompson CH, Zhang J, et al. Sequence variation in the upstream regulatory region of HPV 18 isolates from cervical cancers. Gynecol Oncol. 1997;66:282-289.
25. Modis Y, Trus BL, Harrison SC. Atomic model of the papillomavirus capsid. EMBO J. 2002;21:4754-4762.
26. Sichero L, Villa LL. Epidemiological and functional implications of molecular variants of human papillomavirus. Braz J Med Biol Res. 2006;39:707-717.
27. Bishop B, Dasgupta J, Chen XS. Structure-based engineering of papillomavirus major capsid l: controlling particle assembly. Virol J. 2007;4:3.
28. Combita AL, Touzé A, Bousarghin L, et al. Identification of two cross-neutralizing linear epitopes within the L1 major capsid protein of human papillomaviruses. J Virol. 2002;76:6480-6486.